In the evolving field of biochemical research, the development of specialized molec by C Choi · 2025 · Cited by 3 — Onex was engineered with the VHPK peptide, to construct V-Onex, specifically targeting vascular cell adhesion molecule-1 (VCAM-1), which is strongly upregulated ular tools has opened new doors for precision studies. Among these, the VCAM-1 targeting peptide has emerged as a focal point Vascular Cell Adhesion Molecule 1-Mediated Targeting of for investigators looking to interact with specific cell-surface markers. As someone deeply interested in the mechanics of targeted delivery, I have spent considerable time reviewing the literature regarding how these peptides function as a targeted peptide for advanced experimental models.
The Nature of VCAM-1
VCAM-1, or Vascular Cell Adhesion Molecule 1 (also known as CD106), is a type I transmembrane protein that plays a critical role in cellular recognition. It is an immunoglobulin-like adhesion molecule expressed on activated endothelial cells. In a healthy state, VCAM-1 is expressed at very low levels in ECs, but its expression is significantly upregulated during inflammatory processes. This characteristic makes it a high-value target for researchers aiming to study localized cellular interactions.
The VHPKQHRGGS Vascular Cell Adhesion Molecule 1 - an overview KGC Sequence
The most widely cited VCAM1-binding peptide is characterized by the specific amino acid sequence VHPKQHRGGSKGC. This Vascular cell adhesion molecule-1 binding peptide has demonstrated high affinity for its target, making it a by S Gupta · 2022 · Cited by 2 — VCAM1-binding peptide was conjugated via linker GGSKGC to the biomateri- als. During polymer encapsulation, cells were incubated with peptide cornerstone for those developing VCAM-1 targeting peptide conjugates.
From my perspective, the precision of this peptide is what makes it so valuable. By utilizing a peptide-grafted coating for the nanoparticles, researchers can ensure that these carriers are targeted toward the specific site of interest. This approach—where gene by JR Pickett · 2023 · Cited by 6 — significantly inhibit monocyte transmigration by inhibiting the VCAM-1/VLA-4 interaction,. 12 serving as a base model for future VCAM-1-targeted peptide delivery nanoparticles are targeted to VCAM-1—represents a sophisticated method for site-specific experimental delivery.
Applications and Experimental Observations
My review of current research highlights several key ways this techno Targeting endothelial VCAM-1 in atherosclerosis logy is being utilized:
* Nanoparticle Engineering: Researchers have successfully conjugated this peptide to various surfaces, including quantum dots and liposomes. The targeting is accomplished via a peptide-grafted coating for the nanoparticles, which allows for enhanced interaction with the VCAM-1 molecule.
* Imaging and Detection: The VCAM-1 is a promising target for the non-invasive detection of atherosclerosis and other vascular conditions. By using peptides to facilitate imaging, investigators can visualize molecular changes in real-time.
* Binding Specificity: The interaction between the peptide and the protein is often verified using surface plasmon resonance or fluorescence imaging. Whether it is a CLIO nanoparticle targeted with anti-VCAM-1 antibody or a purely peptide-based system, the goal remains the same: high-affinity binding.
Why This Matters in Research
The utility of a Vascular Cell Adhesion Molecule 1 (VCAM1) Peptide lies in its versatility. Because VCAM-1, an immunoglobulin-like transmembrane glycoprotein, is so distinct in its expression pattern, it serves as an ideal "anchor" for experimental systems.
When I look at the future of this field, I see a clear shift toward more refined, stable, and specific VCAM1 binding peptide derivatives. Whether the focus is on targeting a specific pathway or investigating the mechanical properties of vascular cell adhesion protein 1, the ability to anchor a system directly to the cell surface is revolutionary.
Final Thoughts
For those of us observing the progress in this domain, the VCAM-1 targeting peptide is more than just a sequence of amino acids; it is a vital tool for molecular precision. While the research is primarily for experimental use, the data gathered thus far—such as the efficacy of VCAM-1 targeting peptide in loca VCAM-1, an immunoglobulin-like transmembrane glycoprotein that promotes cell–cell adhesion, is over-expressed on the surface of endothelial cells during lized models—suggests that we are moving toward an era of much higher resolution in our ability to target specific biological markers.
As always, when working with these materials, it is essential to adhere to laboratory safety protocols and ensure th by S Pastorino · 2021 · Cited by 23 — Another way to target VCAM-1 is to exploit peptides that are characterized by high affinity and specificity for VCAM-1 binding: several research at all applications are strictly for research purposes, as these tools are designed for the advancement of science rather than direct application.